Exploring cellular uptake of iron oxide nanoparticles associated with rhodium citrate in breast cancer cells

Nanocarriers have the potential to improve the therapeutic index of currently available drugs by improving their efficacy and achieving therapeutic steady-state levels over an extended period. The association of maghemite–rhodium citrate (MRC) nanoparticles (NPs) has the potential to increase specif...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Nanomedicine
Main Authors: Chaves, Natalia L, Estrela-Lopis, Irina, Böttner, Julia, Lopes, Cláudio AP, Guido, Bruna C, de Sousa, Aparecido R, Báo, Sônia N
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2017
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5546771/
https://ncbi.nlm.nih.gov/pubmed/28814867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S141582
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares